In June, the ten Venture Leaders Medtech 2022 will represent Switzerland and pitch their solutions in Boston, USA. During their weeklong roadshow, the entrepreneurs will meet with investors, experts, and industry leaders to strengthen their network and advance their global growth. To introduce themselves and their startups, the founders met in Lausanne and showcased their innovations at an online pitch session.
During the virtual event on April 28th, the Venture Leaders Medtech 2022 learned more about each other’s innovations, talked about their startups journeys thus far, and pitched their unique medtech solutions. Audience members then voted for the team captain and selected Claudia Scheckel, CEO of Oncobit, for the honor. "I'm really looking forward to meeting everyone in person and getting started working with all of you," said Claudia.aiEndoscopic AG: We combine AI with robotics to develop smart endoscopes
The current scarcity and forecasted shortage of skilled healthcare workers lead to more and more problems in experience-based tasks, such as endoscopy. aiE combines artificial intelligence with rob... Read more
Arbrea Labs AG: AI based AR Surgery Pre-Visualizations on Human Bodies
Arbrea is spearheading the aesthetic metaverse revolution with the first Medical Aesthetic Marketspace powered by AI and Digital Humans. Our cutting-edge AI, AR, and 3D technologies are transforming s... Read more
ArcoScreen SA: Improving drug discovery through patient cell-screening.
ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug discovery. Our revolutionary technology ... Read more
Bearmind SA: Wearable technology to prevent brain injuries in sports
Bearmind is an EPFL spin-off developing and commercializing in-built helmet sensors and software for brain injury prevention and performance monitoring in Sports. We are developing sensors and alg... Read more
EarlySight SA: Imaging early signs of retinal diseases years in advance
EarlySight is developing a medical device to help doctors detect and monitor eye diseases at early stage thanks to unprecedented imaging of the eye. Many eye diseases (e.g. AMD, glaucoma) are starti... Read more
MOMM Diagnostics GmbH: Rapid diagnostic tests for pregnancy complications
MOMM Diagnostics develops rapid, cost-effective diagnostic tests for pregnancy complications. préXclude® is our first test in development to diagnose and prognose preeclampsia a leading cause of death... Read more
Oncobit AG: Enabling personalised cancer care
Oncobit is a spinoff from the University Hospital of Zurich and has developed a scalable and data-driven cancer monitoring platform based on the quantitative and sensitive detection of cancer markers ... Read more
Rea Diagnostics SA: We develop technology to monitor high risk pregnancies
Rea developed the first at-home diagnostic test that tracks biochemical markers of preterm birth (PTB). Our solution allows doctors to continuously follow up pregnant women at risk of PTB to anticipat... Read more
TWIICE SA: Powered exoskeletons for walking assistance
Every year, 250000 people suffer a spinal cord injury leading to permanent paraplegia. TWIICE enables these individuals to live life to the fullest through wearable robotics. We help to overcome human... Read more